-
3
-
-
0025806824
-
-
(c)
-
(c) Englisch, U.; Gauss, D. H. Angew. Chem., Int. Ed. Engl. 1991, 30, 613.
-
(1991)
Angew. Chem., Int. Ed. Engl.
, vol.30
, pp. 613
-
-
Englisch, U.1
Gauss, D.H.2
-
4
-
-
0032476790
-
-
(a) Of the more recent modifications, the protein nucleic acids (PNAs) are worthy of special note. For a comprehensive review, see
-
(a) Of the more recent modifications, the protein nucleic acids (PNAs) are worthy of special note. For a comprehensive review, see: Uhlmann, E.; Peyman, A.; Breipohl, G.; Will, D. W. Angew. Chem., Int. Ed. Engl. 1998, 37, 2797;
-
(1998)
Angew. Chem., Int. Ed. Engl.
, vol.37
, pp. 2797
-
-
Uhlmann, E.1
Peyman, A.2
Breipohl, G.3
Will, D.W.4
-
5
-
-
85037968015
-
-
™), based upon a phosphorothioate internucleotide linkage, was approved by the FDA in August 1998 for treatment of CMV retinitis (for more details please see the Isis pharmaceuticals web site at www.isip.com).
-
™), based upon a phosphorothioate internucleotide linkage, was approved by the FDA in August 1998 for treatment of CMV retinitis (for more details please see the Isis pharmaceuticals web site at www.isip.com).
-
-
-
-
8
-
-
0001412847
-
-
Hirao, T.; Masunaga, T.; Yamada, N.; Ohshiro, Y.; Agawa, T. Bull. Chem. Soc. Jpn. 1982, 55, 909.
-
(1982)
Bull. Chem. Soc. Jpn.
, vol.55
, pp. 909
-
-
Hirao, T.1
Masunaga, T.2
Yamada, N.3
Ohshiro, Y.4
Agawa, T.5
-
10
-
-
0033529898
-
-
and references cited therein
-
(b) Harris, M. C.; Geis, O.; Buchwald, S. L. J. Org. Chem. 1999, 64, 6019 and references cited therein.
-
(1999)
J. Org. Chem.
, vol.64
, pp. 6019
-
-
Harris, M.C.1
Geis, O.2
Buchwald, S.L.3
-
11
-
-
0028299675
-
-
(a) Fukase, K.; Yoshimura, T.; Kotani, S.; Kusumoto, S. Bull. Chem. Soc. Jpn. 1994, 67, 473;
-
(1994)
Bull. Chem. Soc. Jpn.
, vol.67
, pp. 473
-
-
Fukase, K.1
Yoshimura, T.2
Kotani, S.3
Kusumoto, S.4
-
12
-
-
0001611064
-
-
(b) Tanaka, T.; Tamatsukuri, S.; Ikehara, M. Tetrahedron Lett. 1986, 27, 199;
-
(1986)
Tetrahedron Lett.
, vol.27
, pp. 199
-
-
Tanaka, T.1
Tamatsukuri, S.2
Ikehara, M.3
-
13
-
-
0343959655
-
-
and references cited therein.
-
(c) Marugg, J. E.; Burik, A.; Tromp, M.; van der Marel, G. A.; van Boom, J. H. Tetrahedron Lett. 1986, 27, 2271 and references cited therein.
-
(1986)
Tetrahedron Lett.
, vol.27
, pp. 2271
-
-
Marugg, J.E.1
Burik, A.2
Tromp, M.3
Van Der, M.G.A.4
Van Boom, J.H.5
-
15
-
-
85037962116
-
-
The H-phosphonate 12 was synthesised in a similar manner to the H-phosphonate 2, which we have reported previously. The synthesis involves selective TBS-5′-protection of commercially available N-benzoyl-2′-deoxyadenosine, coupling with N,N-diisopropylmethylphosphonamidic chloride and then tetrazole-mediated hydrolysis in methylene chloride.
-
The H-phosphonate 12 was synthesised in a similar manner to the H-phosphonate 2, which we have reported previously. The synthesis involves selective TBS-5′-protection of commercially available N-benzoyl-2′-deoxyadenosine, coupling with N,N-diisopropylmethylphosphonamidic chloride and then tetrazole-mediated hydrolysis in methylene chloride.
-
-
-
|